Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

Sponsor
Tampere University Hospital
Study ID
NCT07594327
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Pelvic exenteration is an exceptionally extensive and very rare surgical procedure, most commonly used in the treatment of locally recurrent cervical cancer among gynecological malignancies. It is typically performed with curative intent when no other treatment options remain feasible. The aim of this study is to examine the quality of life and sexuality of patients who have undergone pelvic exenteration. This observational cross-sectional study utilizes internationally validated questionnaires assessing quality of life and sexual function: EORTC QLQ-C30, EORTC QLQ-CX24, and PISQ-12. The findings of this study will provide important guidance for the selection and planning of pelvic exenteration. Improved understanding of postoperative quality of life will support patient selection and enable more comprehensive and individualized patient counseling.

Key Dates

Start date
May 31, 2026
Status verified
May 2026
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
21 participants (estimated)

Primary Outcome Measure

Self-reporterd quality of life measured by EORTC QLQ-C30 questionnaire [ Time Frame: Cross-sectional at time of inclusion, at least 6 months after pelvic exenteration ]

Related Studies